Micro- And Nanotechnologies-Based Product Development 2021
DOI: 10.1201/9781003043164-13
|View full text |Cite
|
Sign up to set email alerts
|

Liposomal-Based Pharmaceutical Formulations – Current Landscape, Limitations and Technologies for Industrial Scale-Up

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…Liposomes are lipid bilayer structures that can carry therapeutic agents of hydrophilic nature between the core bilayer and lipophilic drugs. Numerous liposome-based medications and biomedical products have been approved for medicinal use in recent years since they are nontoxic . Melatonin (MLT) embedded elastic liposomes employing the method of thin-film dispersion were formulated to slow down the process of skin aging.…”
Section: Vesicular Drug Delivery Systemsmentioning
confidence: 99%
See 1 more Smart Citation
“…Liposomes are lipid bilayer structures that can carry therapeutic agents of hydrophilic nature between the core bilayer and lipophilic drugs. Numerous liposome-based medications and biomedical products have been approved for medicinal use in recent years since they are nontoxic . Melatonin (MLT) embedded elastic liposomes employing the method of thin-film dispersion were formulated to slow down the process of skin aging.…”
Section: Vesicular Drug Delivery Systemsmentioning
confidence: 99%
“…Numerous liposome-based medications and biomedical products have been approved for medicinal use in recent years since they are nontoxic. 175 Melatonin (MLT) embedded elastic liposomes employing the method of thin-film dispersion were formulated to slow down the process of skin aging. These liposomes were prepared with the aim of enhancing the poor solubility and bioavailability limitations associated with the oral administration of MLT.…”
Section: Vesicular Drug Delivery Systemsmentioning
confidence: 99%
“…The drug encapsulation efficiency achieved 90%, reaching a ratio of 800 g irinotecan per mole of phospholipid within liposomes. The half-life of the drug delivered by this system was 56.8 h following administration [170].…”
Section: Liposomal Formulations In Antitumorigenic Drugs and Vaccines...mentioning
confidence: 99%